ACUR.OB Insider Trading Activity and SEC Form 4 Filings
ACUR.OB insider trading summary
No open-market insider purchases or sales of Acura Pharmaceuticals, Inc (ACUR.OB) have been reported on SEC Form 4 in the past 12 months.
Latest ACUR.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 13, 2007 | Peter A Clemens | Senior VP and CFO | Sell | $2K (2,000 @ $1.09) |
| Nov 13, 2007 | Peter A Clemens | Senior VP and CFO | Sell | $64K (60,566 @ $1.05) |
| Nov 13, 2007 | Peter A Clemens | Senior VP and CFO | Sell | $51K (46,000 @ $1.10) |
| Nov 12, 2007 | Peter A Clemens | Senior VP and CFO | Sell | $49K (40,800 @ $1.19) |
| Nov 12, 2007 | Peter A Clemens | Senior VP and CFO | Sell | $29K (23,500 @ $1.25) |
| Nov 12, 2007 | Peter A Clemens | Senior VP and CFO | Sell | $21K (17,500 @ $1.20) |
| Nov 12, 2007 | Peter A Clemens | Senior VP and CFO | Sell | $20K (17,000 @ $1.18) |
| Nov 9, 2007 | Peter A Clemens | Senior VP and CFO | Sell | $23K (18,000 @ $1.26) |
| Nov 9, 2007 | Peter A Clemens | Senior VP and CFO | Sell | $41K (30,000 @ $1.35) |
| Nov 9, 2007 | Peter A Clemens | Senior VP and CFO | Sell | $8K (6,140 @ $1.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.